Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry W Long

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Cancer Research|November 21, 2022
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E Stevens, Guillermo Peluffo, Xintao Qiu, et al.
Cancer Discovery|February 16, 2021
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint BlockadeShengqing Stan Gu, Wubing Zhang, Xiaoqing Wang, et al.
Nature Medicine|September 11, 2019
Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Yotam Drier, Koen M A Dreijerink, et al.
Nature Medicine|July 3, 2019
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Yotam Drier, Koen M A Dreijerink, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Nature Cancer|May 17, 2021
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activityApril C Watt, Paloma Cejas, Molly J DeCristo, et al.
JCI Insight|January 23, 2026
EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapyAtsuko Ogino, Amir Vajdi, Xinmeng Jasmine Mu, et al.
Cancer Cell|May 8, 2026
Whole-genome doubling drives immune evasion by silencing antigen presentationPierre Foidart, Zheqi Li, Xinran Cai, et al.
Nature Communications|October 2, 2021
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancerPaloma Cejas, Yingtian Xie, Alba Font-Tello, et al.
Cell Reports|December 15, 2023
Heterogeneity and transcriptional drivers of triple-negative breast cancerBojana Jovanović, Daniel Temko, Laura E Stevens, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Cancer Research|November 21, 2022
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E Stevens, Guillermo Peluffo, Xintao Qiu, et al.
Cancer Discovery|February 16, 2021
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint BlockadeShengqing Stan Gu, Wubing Zhang, Xiaoqing Wang, et al.
Nature Medicine|September 11, 2019
Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Yotam Drier, Koen M A Dreijerink, et al.
Nature Medicine|July 3, 2019
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Yotam Drier, Koen M A Dreijerink, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Nature Cancer|May 17, 2021
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activityApril C Watt, Paloma Cejas, Molly J DeCristo, et al.
JCI Insight|January 23, 2026
EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapyAtsuko Ogino, Amir Vajdi, Xinmeng Jasmine Mu, et al.
Cancer Cell|May 8, 2026
Whole-genome doubling drives immune evasion by silencing antigen presentationPierre Foidart, Zheqi Li, Xinran Cai, et al.
Nature Communications|October 2, 2021
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancerPaloma Cejas, Yingtian Xie, Alba Font-Tello, et al.
Cell Reports|December 15, 2023
Heterogeneity and transcriptional drivers of triple-negative breast cancerBojana Jovanović, Daniel Temko, Laura E Stevens, et al.
Pageof 10